These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127 [TBL] [Abstract][Full Text] [Related]
3. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications. Paul R; Dorsey JF; Fan Y Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963 [TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells may contribute to the difficulty in treating cancer. Iseghohi SO Genes Dis; 2016 Mar; 3(1):7-10. PubMed ID: 30258875 [TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. Eun K; Ham SW; Kim H BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397 [TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell plasticity and tumor hierarchy. Cabrera MC; Hollingsworth RE; Hurt EM World J Stem Cells; 2015 Jan; 7(1):27-36. PubMed ID: 25621103 [TBL] [Abstract][Full Text] [Related]
7. Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics. Poli V; Fagnocchi L; Zippo A Stem Cells Int; 2018; 2018():4598195. PubMed ID: 29853913 [TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf. Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094 [TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells: current status and evolving complexities. Visvader JE; Lindeman GJ Cell Stem Cell; 2012 Jun; 10(6):717-728. PubMed ID: 22704512 [TBL] [Abstract][Full Text] [Related]
13. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study. Zhu X; Zhou X; Lewis MT; Xia L; Wong S J Theor Biol; 2011 Jan; 269(1):138-49. PubMed ID: 20969880 [TBL] [Abstract][Full Text] [Related]
15. Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies. Huang SD; Yuan Y; Tang H; Liu XH; Fu CG; Cheng HZ; Bi JW; Yu YW; Gong DJ; Zhang W; Chen J; Xu ZY PLoS One; 2013; 8(1):e54579. PubMed ID: 23349932 [TBL] [Abstract][Full Text] [Related]
16. Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors. Sottoriva A; Vermeulen L; Tavaré S PLoS Comput Biol; 2011 May; 7(5):e1001132. PubMed ID: 21573198 [TBL] [Abstract][Full Text] [Related]
17. Die hard: are cancer stem cells the Bruce Willises of tumor biology? Fábián A; Barok M; Vereb G; Szöllosi J Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297 [TBL] [Abstract][Full Text] [Related]
18. Insights into the cell of origin in breast cancer and breast cancer stem cells. Lindeman GJ; Visvader JE Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420 [TBL] [Abstract][Full Text] [Related]
19. A multi-phenotypic cancer model with cell plasticity. Zhou D; Wang Y; Wu B J Theor Biol; 2014 Sep; 357():35-45. PubMed ID: 24819463 [TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and self-renewal. O'Brien CA; Kreso A; Jamieson CH Clin Cancer Res; 2010 Jun; 16(12):3113-20. PubMed ID: 20530701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]